Alvit LCS Pharma

Company Overview

Snapshot

Founded in April 2014 by Itschak Lamensdorf, Nachshol Cohen, and Yoram Sela, Alvit LCS Pharma operates with 1–10 employees. The company specializes in pharmaceutical-grade cannabis product development and drug-delivery technologies. In October 2018, Alvit LCS Pharma announced a manufacturing and licensing agreement with Bazelet, Israel's largest medical cannabis company.

Business overview

Alvit LCS Pharma is a vertically integrated medical cannabis research and development company focused on developing pharmaceutical-grade cannabis products and drug-delivery technologies. The company's product portfolio includes various tablets, sprays, and suppositories. Alvit manages the entire cannabis drug-development lifecycle, from Good Agriculture Practice-controlled cultivation of proprietary cannabis clones and standardized extracts to preclinical evaluations, proprietary formulations, and first-in-human studies, serving the pharmaceutical and healthcare industries across markets like Europe, Israel, and the United States.

Strategic signal

In January 2019, Alvit LCS Pharma sponsored the Cannabis Pavilion in Davos, signaling its commitment to engaging with global economic and political leaders on the future of the cannabis industry. This move highlights the company's strategic intent to position itself at the forefront of policy discussions and market development for medical cannabis, aiming to influence regulatory frameworks and foster international partnerships.

Company Intelligence Q&A

What is Alvit LCS Pharma's core business?

Alvit LCS Pharma is a vertically integrated medical cannabis research and development company specializing in pharmaceutical-grade cannabis product development and drug-delivery technologies.

When was Alvit LCS Pharma founded?

Alvit LCS Pharma was founded in April 2014.

What significant partnership did Alvit LCS Pharma announce in 2018?

In October 2018, Alvit LCS Pharma announced a manufacturing and licensing agreement with Bazelet, Israel's largest medical cannabis company.

What was a key strategic move by Alvit LCS Pharma in early 2019?

In January 2019, Alvit LCS Pharma sponsored the Cannabis Pavilion in Davos, demonstrating its engagement with the global cannabis industry's future.

What was the focus of Alvit LCS Pharma's news in January 2020?

In January 2020, Alvit LCS Pharma was featured in news regarding Europe's search for cannabis flowers, indicating its role in the supply chain for medical cannabis in the European market.